Background We evaluated procalcitonin (PCT) assay in the emergency diagnosis of neonatal bacterial infection, especially in preterm infants, relative to C-reactive protein (CRP) and brinogen.
Introduction
Infection is a major cause of neonatal morbidity and mortality. Infection in neonates is di¤cult to identify solely on the basis of physical ¢ndings because signs are non-speci¢c and may be absent when the infant is infected just before delivery. 1 De¢nitive diagnosis of neonatal sepsis is based on positive blood or cerebrospinal £uid (CSF) culture, which both take at least 24 to 48 h and are often falsely negative. Empiric antibiotic therapy is therefore started immediately when neonatal infection is suspected. Determination of leukocyte indices, C-reactive protein (CRP), elastase and cytokines have been used to establish or rule out neonatal infection and to aid the decision to terminate unwarranted therapy.
2^8
Procalcitonin (PCT) measurement has been developed as an indicator of sepsis. 9 Increased serum PCT concentrations have been found in neonates with severe systemic bacterial, parasitic and fungal infections. However, PCT concentrations may increase during vascular or respiratory distress syndromes. PCT also £uctuates physiologically during the ¢rst days of life, and little is known about the diagnostic value of this marker in premature infants. 10^13 Furthermore, the sensitivity and speci¢city of these markers are controversial. Predictive values can be improved by combining two or more factors, but the results thus obtained are questionable. 5, 14, 15 We performed serial PCT assays during the ¢rst 72 h of life in premature and term neonates to assess the value of this marker for the diagnosis of neonatal infection, relative to CRP and ¢brinogen.
Patients and methods

Patients
One hundred and thirty-six newborn infants with clinical signs of sepsis during the ¢rst 24 h of life (D0) were prospectively enrolled in this study. Sixteen newborns were subsequently excluded because their mothers had received antibiotic therapy just before delivery or were diabetic. 13 The 120 infants ¢nally studied were born at 24^37 weeks of gestation. They were divided into three groups on the basis of clinical signs of infection (hepatosplenomegaly, respiratory distress, bradycardia, hypotension or temperature instability), chest radiographic ¢ndings, the white blood cell count (WBC) and results of bacteriological culture, as follows: 16 uninfected: neonates with transient distress or prematurity, who were bacterial culture-negative; infected: neonates with con¢rmed sepsis, i.e. positive blood or CSF culture; or probable infection, i.e. clinical signs associated with an increased (420£10 9 /L) or decreased (55£10 9 /L) WBC relative to gestational age 17, 18 and positive culture of peripheral samples but with negative blood cultures; unclassi¢ed: neonates with discordant clinical ¢ndings and bacteriological results on peripheral samples.
Antibiotic treatment combining amoxicillin 100 mg/ kg/day, cefotaxime 100 mg/kg/day and netromycin 5 mg/kg/day was started in every case. The treatment was stopped either on the third day (D3) in the absence of bacteriological con¢rmation, or on the seventh to tenth day when the outcome was favourable.
Assays
Blood was collected by peripheral venepuncture at the initial work-up and at various times thereafter for serial determination of biological markers. The WBC was done in EDTA blood (Coulter S plus IV counter, Beckman Coulter France SA, Villepinte, France). Fibrinogen was determined in citrated plasma by a chronometric assay (Fibromat kit, BioMe¨rieux, Marcy l'Etiole, France). 19 CRP was measured in serum by nephelometry on a Beckmann Array analyser (Beckman Coulter France SA). The remaining serum was stored at 7208C until PCT was assayed on a Berilux 250 analyser (Behring Diagnostics, Marburg, Germany) using the immunoluminometric method (Lumitest PCT, Brahms Diagnostica GMBH, Berlin, Germany). 13 When indicated, blood, CSF, urine and peripheral £uids (gastric and ear £uid) were cultured.
Statistical analysis
Results are expressed as median (m), minimum (min) and maximum values (max), as recommended by the International Federation of Clinical Chemistry. 20 Di¡erences between groups were analysed using the Kruskal Wallis test and the Mann^Whitney U test, and were considered signi¢cant at P50 ¢05. To Table 1 .
Fibrinogen, C-reactive protein (CRP) and procalcitonin (PCT) in uninfected pre-term and full-term neonates at birth (D0)
Weeks of gestation
Results are expressed as medians, minimum values (min) and maximum values (max). 
Results
Eighty-eight of the 120 neonates were not infected. Their ¢brinogen, CRP and PCT concentrations on the ¢rst day of life (D0) did not vary signi¢cantly with gestational age (see Table 1 ). Median values were 2¢3 g/L, 5¢1mg/L and 1 ¢ 0 mg/L, respectively (see Table 2 ).
Twenty-one neonates (10 term and 11 premature infants) were considered infected. None of the children died. They had signi¢cantly increased ¢brinogen (4 ¢ 2 g/L), CRP (16 ¢ 0 mg/L) and PCT (12 ¢ 0 mg/L) concentrations on D0, but with wide variations (see Table 2 ). The main clinical signs were respiratory distress (nˆ9) and/or hepatosplenomegaly (nˆ8). Cultures were positive for Escherichia coli K1 (nˆ10), group B streptococci (nˆ5), non K1 E. coli (nˆ2), Pseudomonas aeruginosa (nˆ2), Ureaplasma urealyticum (nˆ1) and Klebsiella pneumoniae (nˆ1) (data not shown).
Eleven newborns were`unclassi¢ed': all had transient respiratory distress associated with a moderate but signi¢cant increase in their WBC (520£10 9 / L). By contrast, their marker concentrations were not signi¢cantly di¡erent from the baseline values of the uninfected children (see Table 2 ).
On D0, ROC analysis gave optimum cut-o¡ values of 3 ¢ 0 g/L for ¢brinogen, 7 ¢ 5 mg/L for CRP and 2 ¢ 5 mg/L for PCT in the diagnosis of sepsis (see Fig. 1 ). PCT was the most valuable marker, both speci¢c (90%) and sensitive (87%) with the greatest negative predictive value (93%), whereas ¢brinogen and CRP lacked sensitivity (see Table 3 ). Combining PCT with either ¢brinogen or CRP did not statistically increase its performance (data not shown).
Fibrinogen, CRP and PCT concentrations were also measured during the ¢rst 3 days of life (D0^D3). In the uninfected newborns, prematurity had no in£uence on marker concentrations corrected for gestational age. Fibrinogen increased gradually from D0 to D3, while CRP and PCT (Pˆ0¢02) peaked on D1 (see Fig. 2 ). CRP and PCT concentrations in the infected newborns both fell signi¢cantly, while ¢brinogen concentrations slowly returned to baseline during antibiotherapy (data not shown).
Discussion
C-reactive protein is the most widely used protein marker of sepsis. 21, 22 Studies of other candidate biological markers are controversial, as CRP was used to de¢ne`infected' status. 10, 11, 13 We distinguished between infected and uninfected newborns on the basis of clinical and bacteriological ¢ndings and the WBC.
16^18`U nclassi¢ed' patients were retrospectively considered as colonized. As maternal antibiotherapy and diabetes can in£uence PCT concentration, these cases were excluded from the study. 13 In contrast to the WBC, CRP and PCT and ¢brinogen concentrations at birth did not vary signi¢cantly with gestational age among uninfected newborns as previously shown. 21, 23 We con¢rmed that PCT and CRP peaked at D1^D2, with large inter-individual variations, while ¢bri-nogen showed a gradual and slight increase. 12 ,23^25 This pattern of evolution was similar whatever the gestational age and sex. The large variability of PCT values may be physiological or result from analytical di¡erences, as di¡erent forms of PCT may circulate. 26 Analysis of ROC curves on D0 gave a CRP cut-o¡ value of 7¢5 mg/L for neonatal sepsis. This value may also be used later on D2 and D3, as it is always above the 95th percentile of CRP concentrations in the uninfected infants. Published CRP values range from 7¢0 to 10¢0 mg/L depending on the study population and assay method, the detection limits and accuracy of which still need to be improved. 5 Circulating concentrations of CRP and its modulation should be revised using the newly developed ultrasensitive test. 27 Fibrinogen determination requires an additional collection of blood and thus its use is reserved for haemostatic evaluation. This marker behaves as an acute phase protein, and a cut-o¡ value of 3¢0 g/L distinguishes infected from uninfected infants at D0 in our study. The PCT cut-o¡ of 2¢5 mg/L is not di¡erent from the upper limit of normal observed at D0 in healthy full-term newborns. 10^13 In contrast to CRP and ¢brinogen, this cut-o¡ value cannot be used after D0, as it is below the 95th percentile of PCT concentrations in uninfected infants. This re£ects the short half-life of PCT and thus the failure of PCT concentration to decline during the antibiotherapy is of prognostic value. Cut-o¡ values for PCT should be established hourly in a larger population to distinguish between physiological and pathological concentrations. For the moment, quantitative measurement of PCT is di¤cult in the emergency setting. Published studies have yielded di¡erent results for sensitivity and speci¢city, probably because they involved di¡erent study populations and cut-o¡ values.
None of the markers studied here can be considered as a gold standard. 28^30 We found no added predictive value when the di¡erent markers were combined, but these markers can be used sequentially. 31, 32 As the involvement of these proteins in in£ammatory and infectious processes is still under investigation, analytical considerations and ¢nancial considerations are the major determinants in the choice of the protein. Unlike PCT, CRP assay is available on numerous automated analysers and therefore should still be considered as the ¢rst-line marker for neonates. However, if CRP values are doubtful, PCT is preferable to ¢brinogen for con¢rmation, as PCT can be assayed on the same sample as CRP.
Procalcitonin had a good negative predictive value compared with CRP and ¢brinogen, con¢rming the value of this marker in excluding infection shortly after birth. PCT can thus be considered as an early marker of bacterial infection, like cytokines and elastase, with apparently better sample stability. 22 
